OXZOVI Trademark

Trademark Overview

On Tuesday, July 9, 2024, a trademark application was filed for OXZOVI with the United States Patent and Trademark Office. The USPTO has given the OXZOVI trademark a serial number of 98639755. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Wednesday, June 11, 2025. This trademark is owned by AstraZeneca AB. The OXZOVI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of respiratory diseases and disorders
oxzovi

General Information

Serial Number98639755
Word MarkOXZOVI
Filing DateTuesday, July 9, 2024
Status686 - PUBLISHED FOR OPPOSITION
Status DateWednesday, June 11, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 17, 2024

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of respiratory diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, July 9, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAstraZeneca AB
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressSodertalje SE-15185
SE
Party NameAstraZeneca AB
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressSodertalje SE-15185
SE

Trademark Events

Event DateEvent Description
Tuesday, July 9, 2024NEW APPLICATION ENTERED
Tuesday, July 9, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, August 5, 2024ASSIGNED TO EXAMINER
Monday, August 12, 2024SUSPENSION LETTER WRITTEN
Monday, August 12, 2024NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, October 18, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, October 18, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, October 18, 2024TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Monday, August 12, 2024LETTER OF SUSPENSION E-MAILED
Saturday, October 19, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, November 12, 2024PREVIOUS ALLOWANCE COUNT WITHDRAWN
Tuesday, November 12, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, November 12, 2024WITHDRAWN FROM PUB - SENIOR ATTORNEY REQUEST
Thursday, November 21, 2024ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Tuesday, December 17, 2024PUBLISHED FOR OPPOSITION
Wednesday, December 11, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 17, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 11, 2025NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, April 24, 2025NOTICE OF ALLOWANCE CANCELLED
Thursday, April 24, 2025TEAS DELETE 1(B) BASIS RECEIVED
Wednesday, June 11, 20251(B) BASIS DELETED; PROCEED TO REGISTRATION

Related Keywords

oxzovi diseases disorders respiratory treatment preparations substances pharmaceutical